tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IDYA Stock Latest News

GSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?
Company AnnouncementsGSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?
8d ago
GSK
IDYA
IDEAYA Biosciences: Hold Rating Amid Key Pipeline Developments and Anticipated Clinical Milestones
PremiumRatings
IDEAYA Biosciences: Hold Rating Amid Key Pipeline Developments and Anticipated Clinical Milestones
8d ago
IDYA
GSK and Ideaya’s Promising Study on Tumor-Reducing Drug GSK4418959
PremiumCompany Announcements
GSK and Ideaya’s Promising Study on Tumor-Reducing Drug GSK4418959
10d ago
GSK
IDYA
IDEAYA Biosciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
IDEAYA Biosciences Reports Q2 2025 Financial Results
11d ago
IDYA
IDEAYA Biosciences: Promising Clinical Data and Strong Financial Health Support Buy Rating
PremiumRatings
IDEAYA Biosciences: Promising Clinical Data and Strong Financial Health Support Buy Rating
11d ago
IDYA
IDEAYA Biosciences: Promising Catalysts and Late-Stage Developments Fuel Buy Rating
PremiumRatingsIDEAYA Biosciences: Promising Catalysts and Late-Stage Developments Fuel Buy Rating
11d ago
IDYA
Ideaya Biosciences reports Q2 EPS (88c), consensus (79c)
Premium
The Fly
Ideaya Biosciences reports Q2 EPS (88c), consensus (79c)
11d ago
IDYA
Ideaya Biosciences Advances in Ocular Melanoma Treatment with Darovasertib Study
Premium
Company Announcements
Ideaya Biosciences Advances in Ocular Melanoma Treatment with Darovasertib Study
12d ago
IDYA
JPMorgan ups Ideaya target, adds to Analyst Focus List
PremiumThe Fly
JPMorgan ups Ideaya target, adds to Analyst Focus List
19d ago
IDYA
IDEAYA Biosciences’ Promising Potential with IDE849: Analyst Charles Zhu’s Buy Rating Ahead of WCLC 2025
PremiumRatings
IDEAYA Biosciences’ Promising Potential with IDE849: Analyst Charles Zhu’s Buy Rating Ahead of WCLC 2025
20d ago
IDYA
Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025
PremiumThe Fly
Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025
25d ago
IDYA
Ideaya Biosciences initiated with a Buy at TD Cowen
PremiumThe Fly
Ideaya Biosciences initiated with a Buy at TD Cowen
25d ago
IDYA
Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences
PremiumRatingsPromising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences
25d ago
IDYA
Ideaya Biosciences resumed with a Neutral at Goldman Sachs
Premium
The Fly
Ideaya Biosciences resumed with a Neutral at Goldman Sachs
1M ago
IDYA
Ideaya Biosciences price target lowered to $30 from $57 at RBC Capital
Premium
The Fly
Ideaya Biosciences price target lowered to $30 from $57 at RBC Capital
1M ago
IDYA
IDEAYA Biosciences Appoints New Chief Financial Officer
PremiumCompany Announcements
IDEAYA Biosciences Appoints New Chief Financial Officer
2M ago
8K
IDYA
General Mills upgraded, Trade Desk downgraded: Wall Street’s top analyst calls
PremiumThe Fly
General Mills upgraded, Trade Desk downgraded: Wall Street’s top analyst calls
2M ago
U
FDS
Ideaya Biosciences initiated with an Overweight at Wells Fargo
PremiumThe Fly
Ideaya Biosciences initiated with an Overweight at Wells Fargo
2M ago
IDYA
IDEAYA Biosciences Holds Annual Stockholders Meeting
PremiumCompany Announcements
IDEAYA Biosciences Holds Annual Stockholders Meeting
2M ago
8K
IDYA
Optimistic Buy Rating for IDEAYA Biosciences: Expanding Market Potential and Promising Clinical Data
PremiumRatingsOptimistic Buy Rating for IDEAYA Biosciences: Expanding Market Potential and Promising Clinical Data
2M ago
IDYA
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
Premium
The Fly
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
3M ago
IDYA
IDEAYA Biosciences: Buy Rating on Anticipated Success of Darovasertib Trial and Stock Appreciation Potential
Premium
Ratings
IDEAYA Biosciences: Buy Rating on Anticipated Success of Darovasertib Trial and Stock Appreciation Potential
3M ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >